SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-11-000279
Filing Date
2011-02-14
Accepted
2011-02-14 18:18:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13G sc13ga407422sup_12312010.htm SC 13G/A 195343
  Complete submission text file 0000921895-11-000279.txt   197296
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
SUPERGEN INC (Subject) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48769 | Film No.: 11608805
SIC: 2834 Pharmaceutical Preparations